Back to Search

HALO

Halozyme Therapeutics, Inc.
Data: 2026-08-07
$103.12
Price
20.24%
Change
$103.30
52W High
$61.23
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Quick Stats
Aug 07, 2026

59.7

AI Score

HOLD

4.3

Volume Ratio

Aug 06, 2026

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

HALO Stock Summary

Last updated Aug 07, 2026

HALO is currently trading at $103.12, positioned above its 200-day moving average of $70.39, indicating a long-term uptrend. The stock has a 52-week range of $61.225 to $103.3.

Technical Analysis: The 50-day moving average stands at $76.21, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 87.264, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.297, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates HALO at 59.7/100 with a HOLD recommendation.

HALO (Halozyme Therapeutics, Inc.) Indicators

Last updated Aug 07, 2026

Indicator Value
RSI(14) 87.264
CMF (20) 0.297
ROC (10) 24.93
ADX (14) 37.932
Indicator Value
MACD (12,26,9) 3.919
AROONOSC (14) 78.571
WILLAMS %R (14) -0.215
MFI (14) 82.036
HALO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

HALO Price vs Max Options Open Interest
HALO Max Change In Options Open Interest

HALO Options - Sort by Max open Interest (near term)

7th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

HALO Daily Out of Money Options - Sort by Max open Interest (near term)

7th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

HALO Daily In the Money Options - Sort by Max open Interest (near term)

7th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

HALO Most Active Options by Volume(near term)

7th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Halozyme Therapeutics, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.

HALO Moving Averages Analysis

Halozyme Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 07, 2026

Halozyme Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 07, 2026

HALO (Halozyme Therapeutics, Inc.) Simple Moving Averages

Moving Averages are last updated Aug 07, 2026

Days MA
10 85.2
20 81.53
30 80.5
50 76.21
100 71.07
200 70.39

HALO Fundamental Analysis

P/E (Forward) 11.534
P/E (Trailing) 29.2273
Market Cap ($) 9.9 billion
Earnings/Share ($) 2.86
Net Profit Margin (%) 0.2313
Dividend/Share ($) --
EPS Estimate Current Year ($) 8.1003
EPS Estimate Next Year ($) 9.9851
WallStreet Target Price ($) 86.89
Most Recent Quarter